Bottom line
"Focus, Stress & Sleep Blend" is a clinic-marketed name for a Semax + Selank + DSIP mixture. The identified listing claims a 10/10/2 mg composition, but a single clinic formulation does not define a standard. No published study of this exact three-component combination was identified.
No established or recommended human dose. The claimed 10/10/2 amount is a market observation, not guidance.
Name and formulation variability
| Observed source/date | Claimed components | Claimed amounts | Verification limits |
|---|---|---|---|
| Beverly Hills Rejuvenation Center (2026) | Semax, Selank, DSIP | 10 / 10 / 2 mg | Clinic-declared market observation; identity and contents not independently verified |
Only one named formulation was identified. That is insufficient to establish either multi-vendor standardization or a stable market definition.
Component evidence
| Component | Separate evidence | Evidence for combination | Compatibility/stability evidence |
|---|---|---|---|
| Semax | See component monograph | None identified for this three-component set | None identified |
| Selank | See component monograph | None identified for this three-component set | None identified |
| DSIP | See component monograph | None identified for this three-component set | None identified |
Combination-specific studies
No published peer-reviewed study testing the exact Semax + Selank + DSIP mixture was identified. The clinic page documents a marketed formulation only.
Safety and interaction uncertainties
No combination-specific human safety, interaction, pharmacokinetic, or toxicology data were identified.
A three-component mixture complicates attribution of any unexpected effect.
Identity, purity, sterility, and co-formulation stability cannot be inferred from clinic marketing.
The stability of the three peptides together was not established by the supplied source.
Regulatory and product-quality notes
"Focus, Stress & Sleep Blend" is not a regulatory or pharmacopoeial formulation name.
A clinic listing is low-quality evidence for market observation and does not establish efficacy, safety, approval, or product quality.
Exact product and jurisdiction must be evaluated separately from the marketing name.
Evidence gaps
No second independent formulation source
No controlled combination study
No independent identity or content verification
No published compatibility or stability data
Sources
Beverly Hills Rejuvenation Center. Semax, Selank & DSIP Blend clinic page. https://bhrcenter.com/peptides/semax-selank-dsip-blend/ accessed 2026-08-08.
Beverly Hills Rejuvenation Center. Peptide services overview. https://bhrcenter.com/peptides/ accessed 2026-08-08.